基因技术工具 · 全部实体（第 26 / 100 页）

本页收录第 2501–2600 条，共 10000 条 · 返回 基因技术工具 首页

• ENCSR907BFG
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR873XLT
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR848NDO
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR648NMQ
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR393ZEG
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR497NTM
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• Review for "Reciprocal abrogation of PKM isoforms: Contradictory outcomes and differing impact of splicing signal on CRISPR/Cas9 mediates gene editing in keratinocytes"
  crossref 2022-09-12T12:36:01Z 置信度 0.70
• Can CRISPR/CAS Help Fight Multidrug Resistance (MDR) Bacterial Infections?
  crossref Ashwani Kumar, Akanksha Kumari, Neha Thakur, Yuan-Yeu Yau 2024-03-18T08:02:35Z 置信度 0.70
• Revolution of CRISPR–Cas: Advancements in genome editing for agriculture
  crossref Rakesh Kumar, Joy Das, K.P. Raghavendra, Supratik Palchoudhury 等 2026-08-28T13:27:27Z 置信度 0.70
• ENCSR064KZR
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR834DVP
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR090ZZP
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR084HUF
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR842FAV
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR030HWI
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR158LDQ
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR678PZO
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR678GKV
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR885KER
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR217BVW
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR834MEV
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR587GQL
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR884YQK
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• CRISPR/Cas9 gene editing: Applications in Parasitology
  Abstract Clustered regularly interspaced short palindromic repeats–CRISPR-associated protein 9 (CRISPR-Cas9) technology is adapted from the bacterial immune system and has rapidly revolutionized the editing of many genomes. This system is based on two componen…
  crossref K E Khalifa 2020-05-05T04:30:07Z 置信度 0.70
• ENCSR898VIA
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR523OQC
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR545FZJ
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR942QWP
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR075BGQ
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR097WJI
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR230BMV
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR124IOF
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• Gene Editing Experiment Using the CRISPR-Cas9 System
  crossref Grace Yongeun Song 2022-07-18T06:54:51Z 置信度 0.70
• ENCSR732SBG
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR420IFR
  crossref B Graveley 2022-03-25T18:27:41Z 置信度 0.70
• ENCSR318PEB
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• ENCSR986FVB
  crossref B Graveley 2023-03-28T23:24:23Z 置信度 0.70
• Gene Silencing and Editing In CNS: SiRNA/CRISPR Loaded Nanovectors
  crossref 2026-01-04T17:26:07Z 置信度 0.70
• Rewriting CAR-T cell fate: CRISPR/Cas gene editing for solid tumor therapy.
  europepmc 2026 置信度 0.80
• Efficient in-vitro regeneration and transformation for CRISPR/Cas9-mediated genome editing of phytoene desaturase (PDS) gene in pea (Pisum sativum L.).
  europepmc 2026 置信度 0.80
• <i>In vivo</i> CRISPR editing for cancer immunotherapy.
  europepmc 2026 置信度 0.80
• A potent EF1A promoter and a minimal U6 promoter enable highly efficient CRISPR genome editing in Aedes aegypti.
  europepmc 2026 置信度 0.80
• Application of CRISPR-Cas9-Based Gene Editing Technology in Inherited Liver Diseases.
  europepmc 2026 置信度 0.80
• Nonhuman Primate Genomes Have Limited Relevance for Evaluating Human CRISPR Off-Target Effects.
  europepmc 2026 置信度 0.80
• CRISPR-Cas9-induced genetic mosaicism in three species of the microcrustacean Daphnia.
  europepmc 2026 置信度 0.80
• A cuffed CRISPR guide RNA for microRNA activity-dependent genome editing
  europepmc 2026 置信度 0.80
• AI-enhanced framework for optimizing CRISPR-Cas gene editing in crop biotechnology addressing regulatory challenges and opportunities in global agricultural practices.
  Introduction The integration of CRISPR Cas genome editing with artificial intelligence (AI) offers significant potential for crop biotechnology by supporting more precise and adaptive strategies for trait improvement under complex agricultural and regulatory c…
  europepmc 2026 置信度 0.80
• A comprehensive review of CRISPR-Cas9-mediated genome editing in Leishmania strains: methodologies, applications, challenges and future directions.
  europepmc 2026 置信度 0.80
• Establishment of an efficient Agrobacterium-mediated transformation system and CRISPR/Cas9-mediated genome editing of the OvPDS1 gene in Oxalis vulcanicola 'Sunset Velvet'.
  europepmc 2026 置信度 0.80
• Highly efficient CRISPR editing enabled by magnetic nanoparticle delivery.
  europepmc 2026 置信度 0.80
• U.S. consumers' processing of information about CRISPR-edited pork products.
  europepmc 2026 置信度 0.80
• Consanguinity-Associated Genetic Disorders in Saudi Arabia: A Hypothesis on the Future Role of CRISPR-Based Gene Editing.
  europepmc 2026 置信度 0.80
• Evaluation of germline transmission of electroporation-mediated double gene-edited cattle lines.
  europepmc 2026 置信度 0.80
• Non-chromatographic purification of guide RNA for gene-editing experiments.
  europepmc 2026 置信度 0.80
• Public knowledge, attitudes, and ethical views on CRISPR-Cas9 gene editing for genetic diseases in Taif, Saudi Arabia.
  europepmc 2026 置信度 0.80
• Efficient Gene Editing in Fish Primary Germline Stem Cells.
  europepmc 2026 置信度 0.80
• Beyond Permanent Genome Editing: Molecular Delivery Strategies for RNA Editing and Epigenome-Editing Therapeutics.
  europepmc 2026 置信度 0.80
• CRISPR-Cas9 mediated knockout of the white gene in the bluetongue virus vector, Culicoides sonorensis (biting midge).
  europepmc 2026 置信度 0.80
• Improving nuclease-and nickase-based homology-directed repair with ZIP CRISPR
  europepmc 2026 置信度 0.80
• Establishment of CRISPR/Cas9 Genome Editing in <i>Ganoderma boninense</i> and Functional Validation of Hydrophobin-2 as a Virulence Determinant.
  europepmc 2026 置信度 0.80
• Systematic Benchmarking of CRISPR-Cas9 Off-Target Prediction Tools Reveals Limitations and Implications for Preclinical Assessment.
  europepmc 2026 置信度 0.80
• EpiCRISPR: Improving CRISPR/Cas9 on- and off-target prediction by flanking sequences, epigenetic marks, and high-throughput datasets.
  europepmc 2026 置信度 0.80
• CRISPR/Cas9-based gene-editing platform development by targeting genes encoding magnesium chelatase and phytoene desaturase in sugarbeet (<i>Beta vulgaris</i> L.).
  europepmc 2026 置信度 0.80
• Gene Editing in <i>Chlamydomonas</i> Using the SCREAM Technique.
  europepmc 2026 置信度 0.80
• Triple-Target CRISPR Strategy to Block HIV Entry and Replication in Permissive Cells.
  europepmc 2026 置信度 0.80
• A dual-dimensional CRISPR toolkit enables one-step high-efficiency multiplex genome editing in Komagataella phaffii.
  europepmc 2026 置信度 0.80
• CRISPR/Cas-based genome editing for enhancing grain quality traits in rice (<i>Oryza sativa</i> L.).
  europepmc 2026 置信度 0.80
• Generation of lachrymatory factor synthase–suppressed onion ( <i>Allium cepa</i> L.) by <i>Agrobacterium</i> -mediated gene transfer for CRISPR/Cas9 genome editing
  europepmc 2026 置信度 0.80
• Gene/Genome Editing in Cardiovascular Biology and Disease.
  europepmc 2026 置信度 0.80
• CRISPR/Cas9 gene editing in the heterotrophic protist <i>Acanthamoeba castellanii</i>
  europepmc 2026 置信度 0.80
• CRISPR-Cas9-based therapies for Huntington's disease and Friedreich's ataxia: mechanisms, advances, and future perspectives.
  europepmc 2026 置信度 0.80
• AI-Driven CRISPR Design: Methods, Tools, Applications and Challenges
  europepmc 2026 置信度 0.80
• STAR Protocols question-and-answer series: CRISPR.
  europepmc 2026 置信度 0.80
• [Construction and characterization of a stable Cas9-expressing monoclonal WSL cell line].
  europepmc 2026 置信度 0.80
• CRISPR-Cas systems as precision antimicrobials: Reversing the tide of antimicrobial resistance.
  europepmc 2026 置信度 0.80
• &lt;i&gt;In vivo&lt;/i&gt; delivery strategies for therapeutic CRISPR genome editing.
  europepmc 2026 置信度 0.80
• Clustered regularly interspaced short palindromic repeats‑associated protein 9 (CRISPR-Cas9) based genome editing in avian primordial germ cells: Comparative technologies, translational applications, and regulatory challenges.
  europepmc 2026 置信度 0.80
• Effect of BRD0539 on Gene Editing and Mosaicism Rate in Porcine Gene Editing Embryos by CRISPR/Cas9.
  europepmc 2026 置信度 0.80
• Programmable gene modulation networks for Parkinson's disease using nanotechnology enabled CRISPR/Cas brain delivery.
  europepmc 2026 置信度 0.80
• The Diversifying Distribution Trends of Maturing CRISPR Technologies by Addgene.
  europepmc 2026 置信度 0.80
• Genome-wide CRISPR screening identifies cellular factors controlling nonviral genome editing efficiency.
  europepmc 2026 置信度 0.80
• AI-Assisted Cross-Study Synthesis in Genome Editing: Comparing Long-Context Strategies and Uncovering Latent Contradictions in the CRISPR-Cas9 Guide RNA Prediction Literature.
  europepmc 2026 置信度 0.80
• CRISPR-Cas-Directed Genome Editing in Maize.
  europepmc 2026 置信度 0.80
• Molecular Intricacies of Modulating Seed Dormancy through CRISPR/Cas9 Technology.
  europepmc 2026 置信度 0.80
• Production of gene-edited cloned cattle embryos using the CRISPR/EOCas12i system.
  europepmc 2026 置信度 0.80
• Gene editing of hematopoietic stem cells: applications and advances.
  europepmc 2026 置信度 0.80
• Inducible CRISPR/Cas systems in precision oncology: Current applications and future perspectives.
  europepmc 2026 置信度 0.80
• Functional assessment of inherited myeloid neoplasm-associated SAMD9L germline variants via Monoallelic CRISPR modelling.
  europepmc 2026 置信度 0.80
• Breaking the growth-defense trade-off in cereal crops: CRISPR/Cas and moonlighting proteins in biotic stress resistance.
  Recurrent crop disease outbreaks linked to global warming pose challenges to sustainable food production. Conventional plant breeding techniques may become less effective at addressing these threats, as improving disease resistance often causes yield reduction…
  europepmc 2026 置信度 0.80
• Market introduction of plant varieties and products with gene-edited traits.
  Gene editing technologies can be used to develop new traits in plants by modifying DNA at specific locations. In many countries, plants made using these techniques, collectively called New Genomic Techniques (NGTs), are being regulated more leniently than tran…
  europepmc 2026 置信度 0.80
• Genetic Engineering of Tumor-Infiltrating Lymphocytes (TIL) via a T-Editor Platform to Enhance Anti-Tumor Activity.
  europepmc 2026 置信度 0.80
• CRISPR Cas9 revolutionizing genetic engineering and therapeutic applications.
  europepmc 2026 置信度 0.80
• A streamlined approach for gene editing in non-obese diabetes (NOD) mice via CRISPR/Cas9.
  europepmc 2026 置信度 0.80
• Prime Editing Mediated Generation and Correction of the mdx5cv Mutation Restores Dystrophin Expression in Myoblasts.
  europepmc 2026 置信度 0.80
• Research on the Boundaries and Risk Assessment of Human Gene Editing Technology Based on YuanXian Theory
  The exponential iteration of gene-editing technologies, particularly the CRISPR-Cas9 system, marks the era where humanity formally wields a mechanical tool to intervene in the foundational code of life. While the mainstream academic narrative concentrates heav…
  datacite Acharya, Zhenyuan 2026 置信度 0.66 YuanXian Theory (YXT); Self-Referential Mind-Field; Gene Editing; CRISPR-Cas9; Biological Evolution; Technical Risk; Germline Modification; Delusion of Presumptuous Modeling (DPM); Somatic Gene TherapyBioethics &amp; Philosophy of ScienceGenetics &amp; Molecular Systems BiologyTechnology Risk Assessment
• Research on the Boundaries and Risk Assessment of Human Gene Editing Technology Based on YuanXian Theory
  The exponential iteration of gene-editing technologies, particularly the CRISPR-Cas9 system, marks the era where humanity formally wields a mechanical tool to intervene in the foundational code of life. While the mainstream academic narrative concentrates heav…
  datacite Acharya, Zhenyuan 2026 置信度 0.66 YuanXian Theory (YXT); Self-Referential Mind-Field; Gene Editing; CRISPR-Cas9; Biological Evolution; Technical Risk; Germline Modification; Delusion of Presumptuous Modeling (DPM); Somatic Gene TherapyBioethics &amp; Philosophy of ScienceGenetics &amp; Molecular Systems BiologyTechnology Risk Assessment
• Pythia: CRISPR-Cas9 gRNA and microhomology repair template design tool
  Web-based tool for designing CRISPR-Cas9 gRNAs and microhomology-based repair templates using deep-learning-predicted repair outcomes. Covers targeted transgene integration, single-nucleotide editing, and N/C-terminal gene tagging across any species, with pre-…
  datacite Yamamoto, Taiyo, Röck, Ruth, Vromant, Koen, Lienkamp, Soeren Sten 等 2026 置信度 0.66 CRISPR-Cas9genome editingmicrohomologyrepair templategRNA design
• Pythia: CRISPR-Cas9 gRNA and microhomology repair template design tool
  Web-based tool for designing CRISPR-Cas9 gRNAs and microhomology-based repair templates using deep-learning-predicted repair outcomes. Covers targeted transgene integration, single-nucleotide editing, and N/C-terminal gene tagging across any species, with pre-…
  datacite Yamamoto, Taiyo, Röck, Ruth, Vromant, Koen, Lienkamp, Soeren Sten 等 2026 置信度 0.66 CRISPR-Cas9genome editingmicrohomologyrepair templategRNA design
• ChanghaoKan/crispr-score-analyzer: v1.0.0 — Initial public release
  🧬 CRISPR Score Analyzer v1.0.0 First public release of CRISPR Score Analyzer — an interactive platform for exploring gene essentiality from DepMap CRISPR screens, designed to make cancer dependency data accessible without writing code. 🚀 Live app: https://cr…
  datacite ChanghaoKan 2026 置信度 0.66
• ChanghaoKan/crispr-score-analyzer: v1.0.0 — Initial public release
  🧬 CRISPR Score Analyzer v1.0.0 First public release of CRISPR Score Analyzer — an interactive platform for exploring gene essentiality from DepMap CRISPR screens, designed to make cancer dependency data accessible without writing code. 🚀 Live app: https://cr…
  datacite ChanghaoKan 2026 置信度 0.66